{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:46:39Z","timestamp":1765961199125,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.tox.2019.152343","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T17:02:38Z","timestamp":1575997358000},"page":"152343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Analysis of \u03b2-catenin gene mutations and gene expression in liver tumours of C57BL\/10J mice produced by chronic administration of sodium phenobarbital"],"prefix":"10.1016","volume":"430","author":[{"given":"James E.","family":"Sidaway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry C.","family":"Orton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassiani","family":"Kalaitzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huw B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5192-919X","authenticated-orcid":false,"given":"Alison","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2019.152343_bib0005","first-page":"2864","article-title":"\u03b2-Catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam","volume":"60","author":"Anna","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2019.152343_bib0010","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/sj.onc.1204982","article-title":"Selective pressure during tumour promotion by phenobarbital leads to clonal outgrowth of \u03b2-catenin-mutated mouse liver tumours","volume":"20","author":"Aydinlik","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2019.152343_bib0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1073\/pnas.88.3.911","article-title":"Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis","volume":"88","author":"Buchmann","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mpo.10180","article-title":"Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects","volume":"39","author":"Buendia","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.tox.2019.152343_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"S1","key":"10.1016\/j.tox.2019.152343_bib0030","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0300-483X(84)90068-4","article-title":"Sustained induction of hepatic xenobiotic metabolising enzyme activities by phenobarbitone in C3H\/He mice: relevance to nodule formation","volume":"33","author":"Collins","year":"1984","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2019.152343_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2019.152343_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2019.152343_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/taap.1994.1005","article-title":"Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam","volume":"124","author":"Cunningham","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.152343_bib0055","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the \u03b2-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"de La Coste","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0060","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/sj.onc.1202858","article-title":"Mutation of \u03b2-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis","volume":"18","author":"Devereux","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2019.152343_bib0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/carcin\/15.5.1083","article-title":"Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet","volume":"15","author":"Devereux","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj2630679","article-title":"Effects of inducers of drug metabolism on basic hepatic forms of mouse glutathione transferase","volume":"263","author":"Di Simplicio","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.tox.2019.152343_bib0075","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1038\/ncomms6944","article-title":"Activating CAR and \u03b2-catenin induces uncontrolled liver growth and tumorigenesis","volume":"6","author":"Dong","year":"2015","journal-title":"Nature Commun."},{"key":"10.1016\/j.tox.2019.152343_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2019.152343_bib0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/019262339202000405","article-title":"The histology and development of hepatic nodules and carcinoma in C3H\/He and C57BL\/6 mice following chronic phenobarbitone administration","volume":"20","author":"Evans","year":"1992","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2019.152343_bib0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/carcin\/7.4.627","article-title":"The histology and development of hepatic nodules in C3H\/He mice following chronic administration of phenobarbitone","volume":"7","author":"Evans","year":"1986","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-642-71617-1_8","article-title":"The histopathology and biochemistry of phenobarbitone-induced liver nodules in C3H\/He mice","volume":"10","author":"Gangolli","year":"1987","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.1016\/j.tox.2019.152343_bib0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/019262301753385979","article-title":"Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys","volume":"29","author":"Gold","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2019.152343_bib0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0940-2993(96)80038-8","article-title":"The evaluation of potential human carcinogens: a histopathologist\u2019s point of view","volume":"48","author":"Greaves","year":"1996","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2019.152343_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-4274(95)80010-B","article-title":"Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice","volume":"76","author":"Griffin","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2019.152343_bib0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/faat.1996.0016","article-title":"Biochemical effects of the mouse hepatocarcinogens oxazepam: similarities to phenobarbital","volume":"29","author":"Griffin","year":"1996","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.152343_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nature Protocol."},{"key":"10.1016\/j.tox.2019.152343_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2019.152343_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1289\/ehp.9193247","article-title":"Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents","volume":"93","author":"Huff","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2019.152343_bib0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.fct.2009.03.014","article-title":"Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL\/10J mouse","volume":"47","author":"Jones","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2019.152343_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.taap.2009.04.018","article-title":"Cytokeratin 8\/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas","volume":"238","author":"Kakehashi","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.152343_bib0145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2019.152343_bib0150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2019.152343_bib0155","first-page":"5685","article-title":"Overexpression of glutamine synthetase is associated with \u03b2-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital","volume":"62","author":"Loeppen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2019.152343_bib0160","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/carcin\/16.11.2617","article-title":"Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation","volume":"16","author":"Malarkey","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0165","first-page":"2524","article-title":"Activation of the \u03b2-catenin gene in primary hepatocellular carcinomas by somatic alterations involving Exon 3","volume":"58","author":"Miyoshi","year":"1998","journal-title":"Cancer Res."},{"year":"1993","series-title":"National Toxicology Program Technical Report Series Number 443. Toxicology and Carcinogenesis Studies of Oxazepam (CAS NO. 604-75-1) in Swiss-webster and B6C3F1 Mice (feed Studies)","author":"NTP","key":"10.1016\/j.tox.2019.152343_bib0170"},{"key":"10.1016\/j.tox.2019.152343_bib0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1039\/C7TX00163K","article-title":"Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice","volume":"6","author":"Ohara","year":"2017","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2019.152343_bib0180","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2131\/jts.42.773","article-title":"Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin","volume":"42","author":"Okuda","year":"2017","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","article-title":"Minimum data sets to establish a CAR-mediated mode of action for rodent liver tumors","volume":"96","author":"Peffer","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2019.152343_bib0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/carcin\/bgq226","article-title":"Tumor formation in liver of conditional \u03b2-catenin-deficient mice exposed to a diethylnitrosoamine\/phenobarbital tumor promotion regime","volume":"32","author":"Rignall","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/carcin\/11.1.145","article-title":"Thymidine kinase and alpha-fetoprotein as biochemical markers of hepatocarcinogenesis induced by 3\u00b4-methyl-4-dimethylaminoazobenzene treatment in rats","volume":"11","author":"Sakamoto","year":"1990","journal-title":"Carciongenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20768","article-title":"Genotype-phenotype relationships in hepatocellular tumors from mice and man","volume":"42","author":"Stahl","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2019.152343_bib0205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/carcin\/15.6.1125","article-title":"Ras mutations in methylclofenapate-indcued B6C3F1 and C57BL\/10J mouse liver tumours","volume":"15","author":"Stanley","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.152343_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/toxsci\/kfl041","article-title":"PCB 153, a non-dioxin-like tumor promoter, selects for \u03b2-catenin (Catnb)-mutated mouse liver tumors","volume":"93","author":"Strathmann","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0215","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.21651","article-title":"WNT\/\u03b2-catenin signaling in liver health and disease","volume":"45","author":"Thompson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2019.152343_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.61.1.1","article-title":"Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital","volume":"61","author":"Ueda","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2019.152343_bib0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/c7tx00288b","article-title":"Case examples of an evaluation of the human relevance of the pyrethroids\/pyrethrins-induced liver tumours in rodents based on the mode of action","volume":"7","author":"Yamada","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2019.152343_bib0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","article-title":"Human hepatocytes support the hypertrophic but not the hyperplastic responses to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver","volume":"142","author":"Yamada","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152343_bib0235","series-title":"Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics","first-page":"417","article-title":"Receptor-mediated regulation of cytochromes P450","author":"Yoshinari","year":"2008"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19303002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19303002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:42:24Z","timestamp":1759534944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19303002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S0300483X19303002"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.152343","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of \u03b2-catenin gene mutations and gene expression in liver tumours of C57BL\/10J mice produced by chronic administration of sodium phenobarbital","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.152343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152343"}}